Patents by Inventor Ralf Geiben Lynn

Ralf Geiben Lynn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SERPIN DRUGS FOR TREATMENT OF VIRAL INFECTION AND METHOD OF USE THEREOF
    Publication number: 20160317628
    Abstract: The invention includes a heparin activated Antithrombin III encapsulated into a sterically stabilized anti-HLA-DR immunoliposome for the treatment of a HIV infection in a human patient.
    Type: Application
    Filed: July 20, 2016
    Publication date: November 3, 2016
    Inventor: Ralf Geiben-Lynn
  • SERPIN DRUGS FOR TREATMENT OF VIRAL INFECTION AND METHOD OF USE THEREOF
    Publication number: 20140044776
    Abstract: The invention includes a heparin activated Antithrombin III encapsulated into a sterically stabilized anti-HLA-DR immunoliposome for the treatment of a HIV infection in a human patient.
    Type: Application
    Filed: October 21, 2013
    Publication date: February 13, 2014
    Inventor: Ralf Geiben-Lynn
  • Method of treating human immunodeficiency virus infection in a mammal comprising administering heparin-activated antithrombin III
    Patent number: 8563693
    Abstract: The invention includes a heparin activated Antithrombin III encapsulated into a sterically stabilized anti-HLA-DR immunoliposome for the treatment of HIV infection in a human patient.
    Type: Grant
    Filed: March 19, 2010
    Date of Patent: October 22, 2013
    Assignee: Acceleration Biopharmaceuticals, Inc.
    Inventor: Ralf Geiben-Lynn
  • SERPIN DRUGS FOR TREATMENT OF HIV INFECTION AND METHOD OF USE THEREOF
    Publication number: 20110008889
    Abstract: The invention includes compositions comprising substantially purified serpin that are useful in methods for the treatment and prevention of HIV, HSV or HCV infection. The invention also includes methods for the treatment and prevention of HIV, HSV or HCV infection comprising contacting a composition of the invention with a human patient or treating HIV, HSV or HCV infection by introducing into a cell susceptible to HIV, HSV or HCV infection, a DNA molecule encoding a serpin.
    Type: Application
    Filed: February 24, 2009
    Publication date: January 13, 2011
    Inventor: Ralf Geiben-Lynn
  • SERPIN DRUGS FOR TREATMENT OF VIRAL INFECTION AND METHOD OF USE THEREOF
    Publication number: 20100255078
    Abstract: The invention includes compositions comprising substantially purified serpin that are useful in methods for the treatment and prevention of HIV, HSV or HCV infection. The invention also includes methods for the treatment and prevention of HIV, HSV or HCV infection comprising contacting a composition of the invention with a human patient or treating HIV, HSV or HCV infection by introducing into a cell susceptible to HIV, HSV or HCV infection, a DNA molecule encoding a serpin.
    Type: Application
    Filed: March 19, 2010
    Publication date: October 7, 2010
    Inventor: Ralf Geiben-Lynn
  • PEROXIREDOXIN DRUGS FOR TREATMENT OF HIV-1 INFECTION AND METHODS OF USE THEREOF
    Publication number: 20090246821
    Abstract: The invention includes compositions comprising substantially purified peroxiredoxin that are useful in methods for the treatment and prevention of HIV-1 infection. The invention also includes methods for the treatment and prevention of HIV-1 infection comprising contacting a composition of the invention with a human patient. Additionally, the invention includes antibodies and kits useful in the treatment and prevention of HIV-1 infection.
    Type: Application
    Filed: August 20, 2008
    Publication date: October 1, 2009
    Applicant: The General Hospital Corporation
    Inventors: Ralf Geiben Lynn, Bruce D. Walker
  • Method of decreasing the infectivity of HIV in a biological sample through the administration of S-antithrombin
    Patent number: 7510828
    Abstract: The invention includes compositions comprising substantially purified serpin that are useful in methods for the treatment and prevention of HIV infection. The invention also includes methods for the treatment and prevention of HIV infection comprising contacting a composition of the invention with a human patient or treating HIV infection by introducing into a cell susceptible to HIV infection a DNA molecule encoding a serpin. Additionally, the invention includes antibodies and kits useful in the detection, treatment, and prevention of HIV infection.
    Type: Grant
    Filed: July 15, 2004
    Date of Patent: March 31, 2009
    Inventors: Ralf Geiben Lynn, Bruce D. Walker
  • Pharmaceutical compositions of antithrombin III for the treatment of retroviral diseases
    Publication number: 20040229778
    Abstract: Pharmaceutical compositions comprised of high molecular weight ATIII are discloses, as is the use thereof in treating infectious diseases, inflammatory disorders and diseases or conditions that are mediated by thrombin activation.
    Type: Application
    Filed: May 13, 2003
    Publication date: November 18, 2004
    Inventors: David R. Elmaleh, Ralf Geiben Lynn
  • Peroxiredoxin drugs for treatment of HIV-1 infection and methods of use thereof
    Publication number: 20020168353
    Abstract: The invention includes compositions comprising substantially purified peroxiredoxin that are useful in methods for the treatment and prevention of HIV-1 infection. The invention also includes methods for the treatment and prevention of HIV-1 infection comprising contacting a composition of the invention with a human patient. Additionally, the invention includes antibodies and kits useful in the treatment and prevention of HIV-1 infection.
    Type: Application
    Filed: January 25, 2002
    Publication date: November 14, 2002
    Inventors: Ralf Geiben Lynn, Bruce D. Walker
  • Serpin drugs for treatment of HIV infection and method of use thereof
    Publication number: 20020127698
    Abstract: The invention includes compositions comprising substantially purified serpin that are useful in methods for the treatment and prevention of HIV infection. The invention also includes methods for the treatment and prevention of HIV infection comprising contacting a composition of the invention with a human patient or treating HIV infection by introducing into a cell susceptible to HIV infection a DNA molecule encoding a serpin. Additionally, the invention includes antibodies and kits useful in the detection, treatment, and prevention of HIV infection.
    Type: Application
    Filed: January 25, 2002
    Publication date: September 12, 2002
    Inventors: Ralf Geiben Lynn, Bruce D. Walker